Sort
39,280 grants matching “leukemia”
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$395,738Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
FANCM in repair of stalled replication forks
$395,738Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$395,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$395,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
FANCM in repair of stalled replication forks
$395,738Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Investigating Abbapolin PLK1 Polo Box Domain inhibitors as potential therapeutics for colorectal cancers
$395,724Campbell McInnes · Ppi Pharmaceuticals, Llc · R41 · FY2025 · CA
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$395,689Ann Marie Pendergast · Duke University · R01 · FY2024 · CA
DDR2 kinase inhibition in squamous cell lung carcinomas
$395,684Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2016 · CA
DDR2 kinase inhibition in squamous cell lung carcinomas
$395,684Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2015 · CA
Redefining the major peanut allergens
$395,635Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2009 · AI
Project 3: Modeling Malignant Myelopoiesis to Increase Efficacy of Targeted Leukemia Therapy
$395,609Richard A. Van Etten · University Of California-Irvine · U54 · FY2021 · CA
Control of Retrovirus CNS Disease by redox modulation
$395,579Paul K Wong · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · NS
Unlocking transcript diversity via differential analyses of splice graphs
$395,553Jan F Prins · Univ Of North Carolina Chapel Hill · R01 · FY2013 · HG
Defining epigenetic mechanisms in NPM1c mutant leukemia
$395,535Scott A Armstrong · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Defining epigenetic mechanisms in NPM1c mutant leukemia
$395,535Scott A Armstrong · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Targeting vulnerabilities of PPM1D-mutant gliomas
$395,535Pratiti Bandopadhayay · Dana-Farber Cancer Inst · R37 · FY2023 · CA
Role of Forkhead Proteins in Insulin Action
$395,522Domenico Accili · Columbia University Health Sciences · R01 · FY2008 · DK
The development of multikinase inhibitors for the treatment of selected cancers
$395,521Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia
$395,510Jeffery M Klco · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma
$395,510Xiang Chen · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Cancer-based discovery of novel mechanisms of chromatin control
$395,510Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
$395,487Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2024 · CA
Molecular Analysis of Normal and Thalassemic DNA
$395,483Stuart H Orkin · Boston Children'S Hospital · R01 · FY2006 · HL
Isocitrate dehydrogenase (IDH) mutations as drivers of organelle stress and dysfunction
$395,448Christal Dyane Sohl · San Diego State University · R35 · FY2025 · GM
A chicken model to study hepatitis E virus pathogenesis
$395,425Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2013 · AI